Lifecore Biomedical, Inc.LFCRNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank43
3Y CAGR-29.3%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-29.3%/yr
Annual compound
Percentile
P43
Within normal range
vs 3Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 8.86% |
| 2024 | 3.83% |
| 2023 | 12.44% |
| 2022 | 25.03% |
| 2021 | -31.85% |
| 2020 | -36.51% |
| 2019 | 23.31% |
| 2018 | -10.75% |
| 2017 | 17.56% |
| 2016 | 23.92% |